Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Danaher; PrimeraDx; Institute for Animal Health

NEW YORK (GenomeWeb News) – Danaher's board of directors has declared a quarterly dividend of $.025 per share. The dividend is payable on Oct. 26 to all shareholders of record on Sept. 28.

PrimeraDx has received the CE Mark for its ICEPlex system and C. difficile detection assay. The ICEPlex is a quantitative multiplex PCR system.

"Obtaining the CE mark on our instrument and assay is an important step in the process of global commercialization of our extensive pipeline of molecular diagnostics products in infectious disease and oncology … and demonstrates to current and future customers, and strategic partners, our ability to develop and support high-quality diagnostic products," PrimeraDx CEO Matt McManus said in a statement.

The Institute for Animal Health in the UK will change its name to The Pirbright Institute, effective Oct. 4, the Biotechnology and Biological Sciences Research Council said this week.

"The new identity, as The Pirbright Institute, represents the coming together of institute science on a single site, the strength of the new science strategy and is a sign of the bright future for Pirbright with over £250M of investment committed to the institute in the coming years," BBSRC Chief Executive Douglas Kell said in a statement.

The Pirbright Institute receives strategic funding from BBSRC and the council is the institute's corporate trustee director.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.